These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34984135)

  • 1. Comparative Safety and Efficacy of Remdesivir Versus Remdesivir Plus Convalescent Plasma Therapy (CPT) and the Effect of Timing of Initiation of Remdesivir in COVID-19 Patients: An Observational Study From North East India.
    Sharma DJ; Deb A; Sarma P; Mallick B; Bhattacharjee P
    Cureus; 2021 Nov; 13(11):e19976. PubMed ID: 34984135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study.
    Koirala J; Gyanwali P; Gerzoff RB; Bhattarai S; Nepal B; Manandhar R; Jha R; Sharma S; Sharma YR; Bastola A; Murphy H; Acharya S; Adhikari P; Rajkarnikari M; Vaidya KM; Panthi CL; Bista B; Giri G; Aryal S; Pant S; Pokharel A; Karki S; Basnet S; Koirala B; Dhimal M;
    Open Forum Infect Dis; 2021 Aug; 8(8):ofab391. PubMed ID: 34430672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success rate of Remdesivir, Convalescent Plasma, and Tocilizumab in moderate to severe Covid-19 pneumonia: our experience in a tertiary care center.
    Mohanty B; Sunder A; Satyanarayan B; Kumar M; Shukla R; Ahmed A
    J Family Med Prim Care; 2021 Nov; 10(11):4236-4241. PubMed ID: 35136795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Remdesivir to the outcomes of hospitalized patients with COVID-19 infection in a tertiary-care hospital in southern India.
    Alexander H; Gunasekaran K; Sara John J; Gracelin Princy Zacchaeus N; Samuel P; Jasmine S; Devasahayam Jesudas Christopher ; Pichamuthu K; Rupali P
    J Infect Dev Ctries; 2023 Mar; 17(3):304-310. PubMed ID: 37023432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients with COVID-19: The Co-CLARITY Trial.
    Gauiran DTV; Dumagay TE; Ang MAC; Dungog CC; Climacosa FMM; Maganito SC; Alfonso RN; Quero AKH; Lucero JAC; Cortez CFN; Evasan ALM; King RAN; Heralde FM; Bonifacio LB; Castillo GJ; Escasa IMS; Santos MCM; Malundo AFG; Mondragon AV; Salamat SEA; Veloso JD; Carnate JM; Tagayuna PY; Lim JA; Alejandria MM; Mirasol MAL
    Acta Med Philipp; 2024; 58(2):5-15. PubMed ID: 38966161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19: retrospective observational cohort study.
    Sattoju N; Gattu S; Merugu SS; Anneboina V; Ganapaka SR
    J Infect Dev Ctries; 2023 Jul; 17(7):953-960. PubMed ID: 37515802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convalescent plasma therapy in obese severe COVID-19 adolescents: Two cases report.
    Cesilia C; Ridar E; Suryawan N; Nataprawira HM
    Ann Med Surg (Lond); 2021 Dec; 72():103084. PubMed ID: 34815868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Use of Remdesivir in Patients Hospitalized With COVID-19 Improves Clinical Outcomes: A Retrospective Observational Study.
    Paranjape N; Husain M; Priestley J; Koonjah Y; Watts C; Havlik J
    Infect Dis Clin Pract (Baltim Md); 2021 Sep; 29(5):e282-e286. PubMed ID: 34539162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early initiation of remdesivir and its effect on oxygen desaturation: A clinical review study among high-risk COVID-19 patients in Myanmar.
    Aye TT; Myat K; Tun HP; Thiha P; Han TM; Win YY; Han AMM
    J Family Med Prim Care; 2022 Aug; 11(8):4644-4649. PubMed ID: 36352909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis.
    Bansal V; Mahapure KS; Mehra I; Bhurwal A; Tekin A; Singh R; Gupta I; Rathore SS; Khan H; Deshpande S; Gulati S; Armaly P; Sheraton M; Kashyap R
    Front Med (Lausanne); 2021; 8():624924. PubMed ID: 33898477
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of Remdesivir-Containing Therapy in Hospitalized COVID-19 Patients: A Prospective Clinical Experience.
    Russo A; Binetti E; Borrazzo C; Cacciola EG; Battistini L; Ceccarelli G; Mastroianni CM; d'Ettorre G
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mortality in patients with severe COVID-19 pneumonia - a retrospective study.
    Mahendra M; Nuchin A; Kumar R; Shreedhar S; Mahesh PA
    Adv Respir Med; 2021; 89(2):135-144. PubMed ID: 33966261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged ICU Stay in Severe and Critically-Ill COVID-19 Patients Who Received Convalescent Plasma Therapy.
    Semedi BP; Ramadhania NN; Tambunan BA; Bintoro SUY; Soedarsono S; Prakoeswa CRS
    Crit Care Res Pract; 2022; 2022():1594342. PubMed ID: 36118915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study.
    Moniuszko-Malinowska A; Czupryna P; Zarębska-Michaluk D; Tomasiewicz K; Pancewicz S; Rorat M; Dworzańska A; Sikorska K; Bolewska B; Lorenc B; Chciałowski A; Kozielewicz D; Oczko-Grzesik B; Szymanek-Pasternak A; Szetela B; Figlerowicz M; Rogalska M; Zaleska I; Flisiak R
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33374333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)-Analysis of Data from Daily Practice.
    Pantazis N; Pechlivanidou E; Antoniadou A; Akinosoglou K; Kalomenidis I; Poulakou G; Milionis H; Panagopoulos P; Marangos M; Katsarolis I; Kazakou P; Dimakopoulou V; Chaliasou AL; Rapti V; Christaki E; Liontos A; Petrakis V; Schinas G; Biros D; Rimpa MC; Touloumi G
    Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of remdesivir in patients with COVID-19 and severe renal insufficiency: a nationwide cohort study in Japan.
    Yamada G; Ogawa Y; Iwamoto N; Suzuki M; Yamada Y; Itaya T; Hayakawa K; Ohmagari N; Yamamoto Y
    Infect Dis (Lond); 2024 Oct; ():1-10. PubMed ID: 39369333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report.
    Anderson J; Schauer J; Bryant S; Graves CR
    Case Rep Womens Health; 2020 Jul; 27():e00221. PubMed ID: 32426243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: A prospective randomised study.
    Mahajan L; Singh AP; Gifty
    Indian J Anaesth; 2021 Mar; 65(Suppl 1):S41-S46. PubMed ID: 33814589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review.
    Roshanshad A; Kamalipour A; Ashraf MA; Roshanshad R; Jafari S; Nazemi P; Akbari M
    Iran J Microbiol; 2020 Oct; 12(5):376-387. PubMed ID: 33603991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.